IDEX Biometrics ASA's Private Placement Completes, Altea AS and Sundt AS Hold 9.40% and 4.93% Ownership Respectively.

IDEX Biometrics ASA completed a private placement of 9,090,909 shares at NOK 3.30 per share on August 20, 2025. Altea AS will hold 5,347,321 shares (9.40% ownership) and Sundt AS will hold 2,804,915 shares (4.93% ownership) in IDEX. This information is disclosed according to the Norwegian Securities Trading Act and published as required.

IDEX Biometrics ASA, a global leader in fingerprint biometrics, recently completed a private placement of 9,090,909 shares at NOK 3.30 per share on August 20, 2025. This transaction resulted in significant changes to the company's shareholding structure, with Altea AS and Sundt AS becoming major shareholders.

Altea AS will hold 5,347,321 shares, representing 9.40% of the company's shares and voting rights, while Sundt AS will hold 2,804,915 shares, equating to 4.93% of the shares and voting rights. The ownership changes were disclosed in accordance with the Norwegian Securities Trading Act and published as required [2].

The share placement was part of a broader strategy to strengthen the company's financial position and align interests among key stakeholders. The transaction follows a previous private placement of 9,090,909 shares at NOK 3.30 per share, which was disclosed on July 21, 2025 [2].

In addition to the share placement, IDEX Biometrics ASA has been implementing various operational improvement initiatives aimed at reducing operational expenses. The company reported a 52% year-over-year reduction in operating expenses, excluding restructuring costs, for the first half of 2025 [1]. The company also announced a target quarterly run rate for operational expenses (OPEX) of $1.5-1.7 million by the end of Q3 2025 [1].

These strategic moves come amidst the company's ongoing efforts to strengthen its management team. On June 1, 2025, Kjell-Arne Besseberg joined IDEX Biometrics ASA as Chief Operating Officer, and on June 30, 2025, Anders Storbråten assumed the role of Chief Executive Officer and Chief Financial Officer, consolidating the two roles to reduce costs and enhance investor relations [1].

References:
[1] https://www.globenewswire.com/news-release/2025/08/27/3139706/0/en/IDEX-Biometrics-ASA-First-half-2025-report.html
[2] https://www.globenewswire.com/news-release/2025/08/27/3139805/0/en/Mandatory-notice-of-shareholding-27-August-2025.html